Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
JOURNALS
PSYCHOPHARMACOLOGY BULLETIN
FULL ISSUE STACKED PDFs
T.E.N.
MENTAL FITNESS
PSI
ONCOLOGY SPECTRUMS
PROJECTS
JOURNAL SUPPLEMENTS
PHYSICIAN ACADEMY SERIES
POCKET REFERENCE GUIDES
TEACHING MONOGRAPHS
MEDWORKS REPRINT SERIES
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
PSYCHIATRIC RATING SCALES
NEWS
Home
Michael E. Thase, MD: Editor’s Letter
Michael E. Thase, MD: Editor’s Letter
$
0.00
Michael E. Thase, MD: Editor's Letter quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 40 No. 3 Articles
Tags:
editors-letter
,
invited-commentary
,
michael-e-thase
,
negative-and-failed-clinical-trial-reports
Description
Description
Michael E. Thase, MD
EDITOR’S LETTER
T
WO
N
EW
S
ECTIONS
O
FFER
F
URTHER
C
HECKS AND
B
ALANCES
: N
EGATIVE AND
F
AILED
C
LINICAL
T
RIAL
R
EPORTS AND
I
NVITED
C
OMMENTARY
Michael E. Thase, MD
Related products
Risperidone: Review of Its Therapeutic Utility in Depression
$
30.00
Add to cart
Details
Psychopharmacology Bulletin VOL 36 Supplement No. 1 – Full Issue Stacked PDF
$
0.00
Add to cart
Details
Optimizing Treatment Outcomes for Patients With Depression and Generalized Anxiety Disorder
$
30.00
Add to cart
Details
Mikael Landén, MD, PhD: A Model to Explain the Therapeutic Effects of Serotonin Reuptake Inhibitors: The Role of 5-HT2 Receptors
$
30.00
Add to cart
Details
Page load link
Go to Top
Michael E. Thase, MD: Editor’s Letter
$0.00
Description
Michael E. Thase, MD
EDITOR’S LETTER
TWO NEW SECTIONS OFFER FURTHER CHECKS AND BALANCES: NEGATIVE AND FAILED CLINICAL TRIAL REPORTS AND INVITED COMMENTARY
Michael E. Thase, MD
Related products
Risperidone: Review of Its Therapeutic Utility in Depression
Psychopharmacology Bulletin VOL 36 Supplement No. 1 – Full Issue Stacked PDF
Optimizing Treatment Outcomes for Patients With Depression and Generalized Anxiety Disorder
Mikael Landén, MD, PhD: A Model to Explain the Therapeutic Effects of Serotonin Reuptake Inhibitors: The Role of 5-HT2 Receptors